INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Fatty Liver & Inflammation desk →

Pooled results from many studies on one question.

36 studies · page 1 of 2

2025 / Umbrella review of systematic reviews with meta-analyses

Ultra-processed food intake was linked to higher risks of all-cause mortality, cardiovascular disease, type 2 diabetes, and colorectal cancer.

An umbrella review analyzed 16 publications of systematic reviews with meta-analyses on ultra-processed food consumption defined by the NOVA classification. Moderate certainty evidence showed increased summary risk ratios for all-cause mortality (SRR per 50 g: 1.02; 95% CI: 1.01, 1.03), cardiovascular disease incidence (per 50 g/d: 1.04; 95% CI: 1.02, 1.06) and mortality (1.05; 95% CI: 1.01, 1.08), type 2 diabetes incidence (per 10%: 1.12; 95% CI: 1.10, 1.13), and colorectal cancer (per 10%: 1.04; 95% CI: 1.01, 1.07). Similar estimates appeared for outcomes like inflammatory bowel diseases, obesity, metabolic syndrome, nonalcoholic fatty liver disease, mental health, and nutrient quality, but certainty was limited. It remains unclear whether food processing itself increases risks or if intake is merely a proxy for poor diet quality.

Shows an association, not proof of cause and effect.

Barbaresko J, Bröder J, Conrad J, et al. Crit Rev Food Sci Nutr, 2025. PMID 38363072

2025 / Systematic review and meta-analysis of RCTs

Phytosterols significantly reduced TC, LDL-C, TG, and blood pressure, and increased HDL-C, but did not alter glycemic, inflammatory, or weight outcomes.

A systematic review and meta-analysis of 109 randomized controlled trials evaluated the effects of phytosterol interventions on cardiovascular risk factors. Dietary phytosterols significantly reduced total cholesterol (MD = -13.41; 95% CI: -15.19, -11.63), LDL-C (MD = -12.57; 95% CI: -13.87, -11.26), triglycerides (MD = -6.34; 95% CI: -9.43, -3.25), SBP (MD = -2.10; 95% CI: -3.27, -0.9), and DBP (MD = -0.83; 95% CI: -0.58, -0.07), while increasing HDL-C (MD = 0.46; 95% CI: 0.13, 0.78). Phytosterols did not significantly alter glucose, HbA1c, IL-6, TNF-α, oxidized LDL-C, BMI, waist circumference, or body weight. The authors noted limitations including a small number of RCTs with small sample sizes for some outcomes and that most included studies were short-term.

Yang Y, Xia J, Yu T, et al. Phytother Res, 2025. PMID 39572895

2024 / Umbrella meta-analysis of randomized controlled trials

Curcumin or turmeric supplementation significantly reduced AST, ALT, HOMA-IR, BMI, and waist circumference in NAFLD patients.

An umbrella meta-analysis analyzed 11 meta-analyses covering 99 randomized controlled trials with 5,546 participants to determine the effects of curcumin/turmeric supplementation in non-alcoholic fatty liver disease. Supplementation significantly reduced AST (ES = -1.072, 95% CI: -1.656, -0.488, p = 0.000), ALT (ES = -0.625, 95% CI: -1.170, -0.134, p = 0.014), HOMA-IR (ES = -0.291, 95% CI: -0.368, -0.214, p = 0.000), BMI (ES = -0.205, 95% CI: -0.304, -0.107, p = 0.000), and waist circumference (ES = -1.290, 95% CI: -2.038, -0.541, p = 0.001). TG was reported with ES = -0.469 (95% CI: -1.057, 0.119, p = 0.128), while effects on GGT, ALP, TC, LDL-C, HDL-C, FBS, HbA1C, and body weight were not significant.

Molani-Gol R, Dehghani A, Rafraf M Phytother Res, 2024. PMID 37918958

2024 / Systematic review of randomized controlled trials

A low-dietary AGE intervention reduced circulating AGEs, oxidative stress, and inflammation, but had modest and inconsistent glycemic and lipid effects.

A systematic review analyzed seven RCTs evaluating low-dietary advanced glycation end-product (L-dAGE) interventions in adult patients with diabetes. Reductions in circulating AGEs were reported in 3/3 studies, along with beneficial effects on oxidative stress in 3/3 studies and inflammatory markers in 4/4 studies. Glucose reductions occurred in 1/6 studies, HbA1c and HOMA changed in 0/6 and 0/3 studies, and lipid profile changed in 1/4 studies. Limitations stated were the small sample size and that dietary and physical activity habits were not considered in most studies.

Detopoulou P, Voulgaridou G, Seva V, et al. Int J Mol Sci, 2024. PMID 39518960

2023 / Systematic review and dose-response meta-analysis of RCTs

Purslane consumption significantly reduced triglycerides, total cholesterol, and CRP, and increased HDL-C in a meta-analysis of randomized controlled trials.

A systematic review and meta-analysis of 13 RCTs evaluated the effects of purslane consumption on lipid profiles and C-reactive protein (CRP). Compared to the control group, purslane consumption significantly reduced serum triglycerides (WMD: -16.72, 95% CI: -22.49, -10.96 mg/dL, p < .001), total cholesterol (WMD: -9.97, 95% CI: -19.86, -0.07 mg/dL, p = .048), and CRP (WMD: -1.22, 95% CI: -1.63, -0.80 mg/L, p < .001). It also significantly increased HDL-C (WMD: 4.09, 95% CI: 1.77, 6.41 mg/dL, p = .001), while LDL-C levels were not affected. According to a suggested optimal dosage, purslane consumption is considered to be safe up to 30 g/day.

Jafari N, Bahreini N, Dehghani A, et al. Food Sci Nutr, 2023. PMID 37970383

2022 / Systematic review and dose-response meta-analysis of controlled trials

Taurine supplementation reduced MDA and CRP levels in controlled trials, but did not significantly alter TNF-α or IL-6.

A systematic review and dose-response meta-analysis of controlled clinical trials evaluated the impact of taurine supplementation on inflammatory and oxidative stress biomarkers. Taurine significantly decreased levels of MDA (SMD = -1.17 µmol/l; 95% CI: -2.08, -0.26; P = 0.012) and CRP (SMD = -1.95 mg/l; 95% CI: -3.20, -0.71; P = 0.002). No significant effects were observed for TNF-α (SMD = -0.18 pg/ml; 95% CI: -0.56, 0.21; P = 0.368) or IL-6 (SMD = -0.49 pg/ml; 95% CI: -1.13, 0.16; P = 0.141). Time-response analysis showed a more pronounced alleviating effect at 56 days (8 weeks) after supplementation (P < 0.05).

Faghfouri AH, Seyyed Shoura SM, Fathollahi P, et al. Eur J Clin Nutr, 2022. PMID 34584225

2022 / Meta-analysis of randomized controlled trials

Curcumin supplementation significantly lowered CRP and hs-CRP concentrations in patients with autoinflammatory conditions.

A meta-analysis evaluated the effect of curcumin supplementation on CRP (9 studies) and hs-CRP (23 studies) in patients with autoinflammatory conditions. Curcumin significantly decreased CRP compared to placebo (WMD = -3.67 mg/L, 95% CI = -6.96 to -0.38, p = 0.02), with significant effects at doses ≤1,000 mg/day and interventions >10 weeks. hs-CRP was also significantly lower than placebo, showing significant effects at doses ≤1,000 mg/day and durations ≤10 weeks, reducing hs-CRP in a non-linear fashion with stronger effects at less than 2,000 mg/day.

Gorabi AM, Abbasifard M, Imani D, et al. Phytother Res, 2022. PMID 34586711

2022 / Systematic review

A systematic review found limited evidence linking caffeinated energy drinks to seizure triggers, but daily coffee and tea up to 400 mg caffeine is not harmful.

This PRISMA-guided systematic review examined the relationship between epilepsy/antiseizure medications and non-alcoholic drinks across 50 included studies (17 human studies, 11 case reports/series, and 22 animal/in vitro studies). None of the included studies provided class 1 evidence. Limited evidence suggests certain beverages, such as caffeinated energy drinks, might trigger seizures. The authors note that coffee/tea consumption is not harmful up to 200 mg caffeine in one sitting or 400 mg daily, while excessive intake of certain fruit juices (e.g., grapefruit, lime, pomegranate, kinnow, star fruit) and caffeinated drinks should be avoided.

Shows an association, not proof of cause and effect.

Asadi-Pooya AA, Zeraatpisheh Z, Rostaminejad M, et al. Acta Neurol Scand, 2022. PMID 34694642

2022 / Systematic review and meta-analysis

High-fructose corn syrup increased CRP compared to sucrose, but showed no significant differences in anthropometric or other metabolic parameters.

A systematic review and meta-analysis evaluated the effects of high-fructose corn syrup (HFCS) versus sucrose across 4 articles with 767 participants, where sweetener usage averaged 19% of daily caloric intake. Compared to sucrose, HFCS intake did not significantly change weight (WMD: -0.29 kg, 95% CI: -1.34 to 0.77, I2 = 0%), waist circumference, BMI, fat mass, TC, HDL, LDL, TG, SBP, or DBP. However, data from three studies showed a significant increase in CRP levels in the HFCS group compared to sucrose (WMD: 0.27 mg/l, 95% CI: 0.02 to 0.52, I2 = 23%).

Li X, Luan Y, Li Y, et al. Front Nutr, 2022. PMID 36238453

2021 / Systematic review and meta-analysis of epidemiological studies

A more pro-inflammatory diet was linked to lower lumbar spine and hip BMD and higher risks of osteoporosis and fractures.

A systematic review and meta-analysis of 11 epidemiological studies with 127,769 participants evaluated the relationship between the Dietary Inflammatory Index (DII) and bone health. Continuous DII was negatively associated with BMD of the lumbar spine (OR: 0.990; 95% CI: 0.984, 0.995) and total hip (OR: 0.995; 95% CI: 0.990, 0.999), but not the femoral neck. Compared with the lowest category, the highest DII category was significantly associated with increased risk of osteoporosis (ES: 1.31; 95% CI: 1.16, 1.48) and fractures (ES: 1.28; 95% CI: 1.03, 1.59).

Shows an association, not proof of cause and effect.

Fang Y, Zhu J, Fan J, et al. Osteoporos Int, 2021. PMID 32740669

2021 / Systematic review and meta-analysis of randomized controlled trials

Grape products containing polyphenols significantly decreased C-reactive protein levels in a meta-analysis of 17 randomized controlled trials.

A systematic review and meta-analysis of 17 randomized controlled trials with 668 participants evaluated the effect of grape products containing polyphenols on C-reactive protein (CRP) levels. Grape products significantly reduced CRP levels (SMD = -0.229; 95% CI -0.41, -0.05; P = 0.013). Subgroup analyses showed significant effects with higher doses (>500 mg/d), longer durations (≥12 weeks), in patients with a clinical condition, and across grape seed extract, grape extract, juice, and raisins. Meta-regression indicated that CRP levels depended on the dose and duration of supplementation.

Sarkhosh-Khorasani S, Hosseinzadeh M Br J Nutr, 2021. PMID 32921322

2021 / Systematic review and meta-analysis of controlled clinical trials

Spirulina supplementation initially increased IL-2 (becoming nonsignificant in sensitivity analysis) with marginal decreases in IL-6 and TBARS.

A systematic review and meta-analysis of 11 controlled clinical trials with 465 subjects evaluated the effects of spirulina on inflammation and oxidative stress. Pooled results showed a significant increase in IL-2 (SMD = 2.69 pg/mL; 95% CI: 0.26, 5.11; P = .03), though this became insignificant after sensitivity analysis (SMD = 0.54 pg/mL; 95% CI: -1.29, 2.27; P > .05). Marginal reductions were observed for IL-6 (SMD = -0.72 mg/dL; 95% CI: -1.50, 0.07; P = .073) and TBARS (SMD = -0.65; 95% CI: -1.37, 0.08; P = .08), with subgroup analyses showing significant reductions when baseline BMI was under 25 kg/m2. No significant effects were observed for TNF-α (SMD = -0.07 mg/dL; P = .56) or MDA (SMD = -0.42; P = .14).

Mohiti S, Zarezadeh M, Naeini F, et al. Clin Exp Pharmacol Physiol, 2021. PMID 33908048

2021 / Systematic review and meta-analysis of RCTs

A meta-analysis found that grape products significantly reduced serum C-reactive protein levels in adults, but did not significantly affect other markers.

A systematic review and meta-analysis of 24 RCTs (27 arms) evaluated the effects of grapes and grape products on inflammatory and oxidative stress markers in adults. Grape products significantly reduced serum C-reactive protein levels (WMD: -0.35 mg/L; 95% CI: -0.62, -0.09, p = .008). However, no significant effects were observed for TNF-alpha (WMD = -1.08 pg/ml; p = .07), IL-6 (WMD = 0.13 pg/ml; p = .60), TAC (WMD = 0.15; p = .54), or MDA (WMD = 0.14; p = .72). The authors noted that further studies are warranted before definitive conclusions can be reached.

Ghalishourani SS, Farzollahpour F, Shirinbakhshmasoleh M, et al. Phytother Res, 2021. PMID 33908079

2021 / Umbrella review of meta-analyses of randomized controlled trials

Current evidence does not support resveratrol supplementation for managing cardiometabolic risk factors in patients with type 2 diabetes, MetS, or NAFLD.

An umbrella review analyzed meta-analyses of randomized controlled trials examining resveratrol supplementation compared to control groups in patients with type 2 diabetes, metabolic syndrome, and NAFLD. While resveratrol showed beneficial effects on some markers (such as blood pressure, lipids, glycemic control, and waist circumference), the magnitude of effect was generally trivial, evidence certainty was very low to low, or trials were too few. Resveratrol showed a clinically important short-term (<12 weeks) reduction in HbA1c (mean difference: -1.05%, 95% CI: -2.09% to -0.02%; n = 6; moderate certainty), though evidence overall does not support supplementation for cardiometabolic management.

Zeraattalab-Motlagh S, Jayedi A, Shab-Bidar S Am J Clin Nutr, 2021. PMID 34320173

2020 / Systematic review and meta-analysis of randomized controlled trials

Regular dietary olive oil intake reduces inflammatory markers in randomized controlled trials.

A systematic review and meta-analysis summarized findings from randomized controlled trials examining regular dietary olive oil consumption. Olive oil intake reduced levels of inflammatory markers, particularly interleukin-6, C-reactive protein, and tumor necrosis factor-alpha. The authors noted that additional research comparing olive oil to other dietary fats is still needed, accounting for varying daily dosages and intervention durations.

NANO counterpoint →

Fernandes J, Fialho M, Santos R, et al. Nutrition, 2020. PMID 31539817

2020 / Systematic review and meta-analysis of RCTs

Dietary anthocyanins reduce multiple markers of systemic and vascular inflammation in trials.

A meta-analysis of 32 randomised controlled trials evaluated dietary anthocyanins on inflammatory markers. Anthocyanin supplementation significantly reduced C-reactive protein (-0.33 mg/l, 95% CI: -0.55 to -0.11), IL-6 (-0.41 ρg/ml, 95% CI: -0.70 to -0.13), TNF-α (-0.64 ρg/ml, 95% CI: -1.18 to -0.09), ICAM-1 (-52.4 ng/ml, 95% CI: -85.7 to -19.1), and VCAM-1 (-49.6 ng/ml, 95% CI: -72.7 to -26.5), while increasing adiponectin (0.75 μg/ml, 95% CI: 0.23 to 1.26). Interleukin-1β and P-selectin did not significantly change.

Fallah AA, Sarmast E, Fatehi P, et al. Food Chem Toxicol, 2020. PMID 31669599

2020 / Meta-analysis of randomized controlled trials

Pomegranate supplementation lowered select inflammatory markers but not endothelial adhesion molecules in adults

A meta-analysis of 16 randomized controlled trials with 572 participants evaluated the effects of pomegranate supplementation compared to placebo. Pomegranate intake significantly lowered hs-CRP (WMD: -6.57 mg/L, 95% CI: -10.04 to -3.10), IL-6 (WMD: -1.68 pg/mL, 95% CI: -3.52 to 0.157), and TNF-alpha (WMD: -2.37 pg/mL, 95% CI: -3.67 to -1.07). However, no significant effects were observed for CRP, E-selectin, ICAM, VCAM, or MDA.

Wang P, Zhang Q, Hou H, et al. Complement Ther Med, 2020. PMID 32147056

2020 / Systematic review and meta-analysis of clinical trials

Ginger supplementation significantly impacts circulating markers of inflammation and oxidative stress.

A systematic review and meta-analysis of 20 articles covering 25 trials evaluated ginger intake relative to controls. Pooled findings indicated that ginger supplementation exerted statistically significant effects on serum CRP, TNF-α, IL-6, TAC, and MDA concentrations. A marginally significant influence was detected for serum PGE2, while heterogeneity diminished across subgroup evaluations based on trial duration, age, dosage, and quality.

Jalali M, Mahmoodi M, Moosavian SP, et al. Phytother Res, 2020. PMID 32147845

2019 / Systematic review and meta-analysis of randomized controlled trials

Resveratrol supplementation significantly reduced serum CRP levels in adults, but showed no overall effect on IL-6 or TNF-α.

A systematic review and meta-analysis of 15 randomized controlled trials evaluated the effects of resveratrol supplementation in 658 adults aged 18 to 75 years. Resveratrol significantly reduced serum CRP levels (WMD = -0.54; 95% CI: -0.78, -0.30; P < 0.0001), but had no overall significant effect on IL-6 (WMD = -0.06; 95% CI: -0.27, 0.14) or TNF-α (WMD = -0.20; 95% CI: -0.55, 0.16). Subgroup analyses found resveratrol intake reduced TNF-α in young subjects (WMD = -0.34; 95% CI: -0.57, -0.12) and obese individuals (WMD = -1.52; 95% CI: -2.87, -0.16). High heterogeneity was present across the analyses.

Haghighatdoost F, Hariri M Eur J Clin Nutr, 2019. PMID 30013206

2019 / Systematic review and meta-analysis of observational studies

A more pro-inflammatory diet, as measured by higher Dietary Inflammatory Index scores, was linked to an increased risk of prostate cancer.

A meta-analysis of five case-control studies and one cohort study was conducted to evaluate the link between the Dietary Inflammatory Index (DII) and prostate cancer risk. The adjusted pooled relative risk of prostate cancer comparing the highest to the lowest DII categories was 1.74 (95% CI: 1.24-2.43). When evaluated as a continuous variable, the risk of prostate cancer was 9% higher for each one-point increase in the DII score.

Shows an association, not proof of cause and effect.

Mohseni R, Abbasi S, Mohseni F, et al. Nutr Cancer, 2019. PMID 30273060

2019 / Systematic review and meta-analysis of randomized controlled trials

Garlic supplementation significantly reduced serum C-reactive protein levels in a meta-analysis of randomized controlled trials.

A systematic review and meta-analysis of nine randomized controlled trials with a total sample size of 363 evaluated the effects of garlic supplementation on serum C-reactive protein (CRP) levels. Compared with controls, garlic intake significantly reduced serum CRP concentrations by 0.8 mg/L (95% CI [-1.5, -0.1], p = 0.02), with evidence of heterogeneity among studies. Subgroup analyses showed significant reductions of 0.82 mg/L (95% CI [-1.02, -0.62], p < 0.001) in trials with doses ≥1,200 mg/day and 2.44 mg/L (95% CI [-4.02, -0.87], p = 0.002) in trials with baseline CRP ≥2 mg/L.

Taghizadeh M, Hamedifard Z, Jafarnejad S Phytother Res, 2019. PMID 30370629

2019 / Systematic review and meta-analysis

Vegetarian dietary patterns were associated with lower levels of inflammatory and immune markers.

A meta-analysis of 30 observational studies compared inflammatory and immune markers between vegetarian and non-vegetarian patterns. Vegetarian patterns were linked to significantly lower levels of C-reactive protein (WMD -0.61 mg/L, 95% CI -0.91 to -0.32), fibrinogen (WMD -0.22 g/L, 95% CI -0.41 to -0.04), and total leukocytes (WMD -0.62 x 10^3/uL, 95% CI -1.13 to -0.10). Data from 10 intervention studies were insufficient to perform a meta-analysis.

Craddock JC, Neale EP, Peoples GE, et al. Adv Nutr, 2019. PMID 30947338

2019 / Meta-analysis of randomized controlled trials

Garlic supplementation reduced circulating inflammatory markers CRP, IL-6, and TNF in adults.

A meta-analysis of 16 randomized controlled trials evaluated garlic doses between 12 and 3,600 mg daily for 2 to 52 weeks. Garlic administration lowered serum C-reactive protein (WMD -0.61 mg/L, 95% CI -1.12 to -0.11), IL-6 (WMD -0.73 ng/L, 95% CI -1.06 to -0.40), and TNF (WMD -0.26 ng/L, 95% CI -0.41 to -0.12). Conversely, garlic exerted no significant effect on adiponectin or leptin levels.

Darooghegi Mofrad M, Milajerdi A, Koohdani F, et al. J Nutr, 2019. PMID 30949665

2019 / Systematic review and meta-analysis of randomized controlled trials

Oral turmeric and curcumin did not significantly lower inflammatory markers in chronic inflammatory conditions.

A systematic review and meta-analysis of 19 randomized controlled trials with follow-ups from 4 to 16 weeks examined oral turmeric (5 trials, n = 356) and curcumin (14 trials, n = 988). Compared to controls, interventions did not significantly lower CRP (MD -2.71 mg/L, 95% CI -5.73 to 0.31), hsCRP (MD -1.44 mg/L, 95% CI -2.94 to 0.06), IL-1 beta, IL-6, or TNF alpha. High heterogeneity was observed for most markers.

White CM, Pasupuleti V, Roman YM, et al. Pharmacol Res, 2019. PMID 31121255